SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, attributed to stronger demand for Amtagvi and Proleukin, is driving the rally and bullish reaction. Traders are also focused on anticipated lung cancer data, while short-squeeze and takeover talk remains speculative.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFAs move to let Fannie Mae and Freddie Mac use VantageScore alongside FICO is driving concern that competition could weaken FICOs mortgage-scoring dominance and pricing power. Traders are divided between viewing the selloff as an overreaction and expecting further pressure from market-share and pricing risks.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as long-term Treasury yields surge amid persistent inflation concerns, heavy government borrowing, and expectations that rates will stay higher or rise further. Traders are split between viewing the selloff as an oversold buying opportunity and expecting further losses, while debating whether elevated yields could eventually weigh on stocks.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for a U.S. Army program to develop next-generation silicon-carbide power semiconductors sparked attention, with traders viewing it as technology validation and a potential route to future defense and infrastructure opportunities. The shares sharp reversal after an initial pop fueled debate over whether the awards long-term promise outweighs the lack of disclosed contract value and near-term revenue; some traders also blamed short selling or manipulation, without evidence establishing those claims.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly earnings beat expectations, with record bookings and stronger full-year guidance driving a sharp share-price jump. Bulls are celebrating the results and demand outlook, while skeptics point to fuel-cost pressures, weaker fourth-quarter expectations and potential profit-taking after the rally.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Rising Treasury yields and expectations for further Fed rate hikes are weighing on rate-sensitive small caps, with traders highlighting IWMs underperformance versus large-cap tech. The conversation is split between calls for more downside and hopes that oversold conditions could support a bounce, particularly if yields and oil-related inflation pressures ease.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp Treasury selloff and surging yields are dominating SPY discussion, with traders warning that higher borrowing costs and debt or inflation concerns could pressure stocks. Others point to equities resilience and possible rebounds, leaving the conversation split amid choppy trading.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Jobys Texas eIPP flights, autonomous-flight demonstrations and progress toward final-stage FAA certification are drawing attention as steps toward future commercial operations. Bulls view the milestones as validation, while skeptics focus on the stocks continued weakness, cash burn, potential dilution and the uncertain certification timeline.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths merger and planned Nasdaq listing under XRPN, alongside its proposed XRP treasury strategy, are driving attention as traders react to the registration filing and trading halts. The community is largely bullish on the potential XRP exposure and warrants, while some remain cautious about merger completion, redemptions, and valuation.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

A sharp ZBCN move has sparked breakout and altcoin-season speculation, with traders also highlighting Zebecs payroll and card products and staking rewards. Some attribute the move to a possible Robinhood connection, but that remains unconfirmed; skeptics warn that past pumps have quickly reversed and question whether adoption is translating into sustained demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GRNF is now the $MAJI  ticker (Merged?) and will change again as it is now Exousia Pro which is the company website now: https://exousiapro.com 
 
Twitter address is: 
 
 https://x.com/Exousia_Pro/status/1945897889919828163 
 
https://exousiapro.com/portfolio/ 
This is great read: 
https://exousiapro.com/wp-content/uploads/2025/02/ExousiaPro-Investor-Presntation-Deck-1-31-25.pdf 
 
https://exousiapro.com/why-exosomes/ 
 
https://www.youtube.com/watch?v=9hF7M2i7Fdw 
 
Enjoy!!! The real ride is about to begin. 
 
Sounds like they have figured out the key to 100 elimination of Glioblastoma Brain Cancer

Sandy Stock

Exousia Pro is a clinical stage biotechnology company developing new ways to exploit the therapeutic potential of exosomes initially focused in the field of oncology. The company's patented manufacturing process utilizes plant based materials to create exosomes used in a number of commercial applications from dermatology to dentistry.

Exousiapro

How To Contact us

MAJI - Dr. Marvin Hausman, our Consultant and Chairman of our SAB, is developing a white paper on exosome safety. This paper will leverage AI to analyze extensive historical exosome data. The insights gained from this analysis are intended to support future IND submissions to... pic.twitter.com/SUPOYi92DK

X (Formerly Twitter)

Exousia Pro on X (formerly Twitter): "$MAJI - Dr. Marvin Hausman, our Consultant and Chairman of our SAB, is developing a white paper on exosome safety. This paper will leverage AI to analyze extensive historical exosome data. The insights gained from ...

PR Newswire ST. PETERSBURG, Fla., Jan. 6, 2025 Pursing commercial applications in skincare serving a growing market of $310 million ST. PETERSBURG, Fla., Jan. 6, 2025 /PRNewswire/ - Marijuana, Inc. (OTCPINK: MAJI), dba Exousia Pro, Inc., has acquired 100% of Exousia AI in a cash and stock transaction from Ludwig Enterprises, Inc.

Press Releases

" We are revolutionizing the potential of plant-derived exosomes as a botanical substitute for human exosomes " Exosomes were first discovered in the 1980s, when researchers initially observed small vesicles being secreted by cells. These vesicles were believed to be cellular debris or byproducts of cell turnover.

Exosomes

Exosomes EXPLAINED ** Click here to view our FULL course on Drug Development: https://biotechprimer.com/drug-development-courses/** Exosomes are teeny tiny sacks in each of our cells. They're about one one-hundredth the size of a typical human cell. They're microscopic parcels secreted from cells and filled with cellular waste-RNA, proteins, and remnants of metabolic processes.

YouTube

StockTwits Web

GRN Holding Corp

 is now the $MAJI  ticker (Merged?) and will change again as it is now Exousia Pro which is the company website now: 

/wp-content/uploads/2025/02/ExousiaPro-Investor-Presntation-Deck-1-31-25.pdf 
 


 
 
Enjoy!!! The real ride is about to begin. 
 
Sounds like they have figured out the key to 100 elimination of Glioblastoma Brain Cancer

BCE_TechMaster

$GRNF is no more. It is now $MAJI and will become a newer ticker for ExousiaPro (that has it&#39;s own website  
 
News:  
 
https://www.youtube.com/watch?v=WQqtJIi-MIY 
1:15 
is where to start  
$MAJI Glioblastoma Brain cancer cure with new tech using Exosomes is the topic.

On August 18th, 2025, four innovative companies gathered to discuss the various aspects of glioblastoma drug development. 00:00:00 Start 00:00:40 Agenda 00:04:40 Advances in Pre-clinical models and patient-derived brain organoids for Glioblastoma. Bryan Vought GaudiBio, Inc 00:42:24 Enabling non-invasive precision medicine in Neuro-oncology.

Go to the moon! Glioma & Glioblastoma Mini Symposium Aug 18 2025

 is no more. It is now $MAJI and will become a newer ticker for ExousiaPro (that has it's own website  
 
News:  
 


 
1:15 
is where to start  
$MAJI Glioblastoma Brain cancer cure with new tech using Exosomes is the topic.